Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105553 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shuoye Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Silicon Dioxide, Drug Resistance, Neoplasm, Nanoparticles, Doxorubicin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Key Teacher of Colleges and Universities of Henan province, Key R&D and Promotion projects of Henan Province, Cultivation Programme for Young Backbone Teachers in Henan University of Technology.
Abstract (Originalsprache)
Multidrug resistance (MDR) is frequently induced after long-term exposure to reduce the therapeutic effect of chemotherapeutic drugs, which is always associated with the overexpression of efflux proteins, such as P-glycoprotein (P-gp). Nano-delivery technology can be used as an efficient strategy to overcome tumor MDR. In this study, mesoporous silica nanoparticles (MSNs) were synthesized and linked with a disulfide bond and then coated with lipid bilayers. The functionalized shell/core delivery systems (HT-LMSNs-SS@DOX) were developed by loading drugs inside the pores of MSNs and conjugating with D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and hyaluronic acid (HA) on the outer lipid surface. HT-LMSNs-SS and other carriers were characterized and assessed in terms of various characteristics. HT-LMSNs-SS@DOX exhibited a dual pH/reduction responsive drug release. The results also showed that modified LMSNs had good dispersity, biocompatibility, and drug-loading capacity. In vitro experiment results demonstrated that HT-LMSNs-SS were internalized by cells and mainly by clathrin-mediated endocytosis, with higher uptake efficiency than other carriers. Furthermore, HT-LMSNs-SS@DOX could effectively inhibit the expression of P-gp, increase the apoptosis ratios of MCF-7/ADR cells, and arrest cell cycle at the G0/G1 phase, with enhanced ability to induce excessive reactive oxygen species (ROS) production in cells. In tumor-bearing model mice, HT-LMSNs-SS@DOX similarly exhibited the highest inhibition activity against tumor growth, with good biosafety, among all of the treatment groups. Therefore, the nano-delivery systems developed herein achieve enhanced efficacy towards resistant tumors through targeted delivery and redox-responsive drug release, with broad application prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
- Key Laboratory of Functional Molecules for Biomedical Research, Zhengzhou 450001, China.
ORCID-Profile: Shuoye Yang
Förderung
- Foundation for Key Teacher of Colleges and Universities of Henan province
- Key R&D and Promotion projects of Henan Province
- Cultivation Programme for Young Backbone Teachers in Henan University of Technology
- Natural Science Innovation Fund of Henan University of Technology
- Key R&D and Promotion projects of Henan Province
Zitieren
APA
Yang, S., Zhang, B., Zhao, X., Zhang, M., Zhang, M., Cui, L., & Zhang, L. (2024). Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105553
Vancouver
Yang S, Zhang B, Zhao X, Zhang M, Zhang M, Cui L, et al. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105553
BibTeX
@article{Yang2024,
author = {Yang, Shuoye and Zhang, Beibei and Zhao, Xiangguo and Zhang, Mengwei and Zhang, Mengna and Cui, Lan and Zhang, Lu},
title = {Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105553}
}
EUVIMED